References:
[1] Wali Y, Kini V, Yassin MA. Distribution of sickle cell disease
and assessment of risk factors based on transcranial Doppler values in
the Gulf region. Hematology. 2020 Jan 1;25(1):55-62.
[2] Menapace LA, Thein SL. COVID-19 and sickle cell disease.
Haematologica 2020;105:2501–4.
https://doi.org/10.3324/haematol.2020.255398.
[3] de Sanctis V, Canatan D, Corrons JL, Karimi M, Daar S, Kattamis
C, Soliman AT, Wali Y, Alkindi S, Huseynov V, Nasibova A. Preliminary
Data on COVID-19 in patients with hemoglobinopathies: A multicentre
ICET-A study. Mediterranean Journal of Hematology and Infectious
Diseases. 2020;12(1).
[4] Beerkens F, John M, Puliafito B, Corbett V, Edwards C, Tremblay
D. COVID-19 pneumonia as a cause of acute chest syndrome in an adult
sickle cell patient. Am J Hematol 2020;95:E154–6.
https://doi.org/10.1002/ajh.25809.
[5] Chakravorty S, Padmore-Payne G, Ike F, Tshibangu V, Graham C,
Rees D, et al. COVID-19 in patients with sickle cell disease – A case
series from a UK tertiary hospital. Haematologica 2020;105:2691–3.
https://doi.org/10.3324/haematol.2020.254250.
[6] Balanchivadze N, Kudirka AA, Askar S, Almadhoun K, Kuriakose P,
Fadel R, et al. Impact of COVID-19 Infection on 24 Patients with Sickle
Cell Disease. One Center Urban Experience, Detroit, MI, USA. Hemoglobin
2020. https://doi.org/10.1080/03630269.2020.1797775.
[7] Okar L, Aldeeb M, Yassin MA. The role of red blood cell exchange
in sickle cell disease in patient with COVID‐19 infection and pulmonary
infiltrates. Clin Case Reports 2020:ccr3.3526.
https://doi.org/10.1002/ccr3.3526.
[8] Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C,
Gulyaeva AA, et al. The species Severe acute respiratory
syndrome-related coronavirus: classifying 2019-nCoV and naming it
SARS-CoV-2. Nat Microbiol 2020;5:536–44.
https://doi.org/10.1038/s41564-020-0695-z.
[9] AbdulRahman A, AlAli S, Yaghi O, Shabaan M, Otoom S, Atkin SL,
et al. COVID-19 and sickle cell disease in Bahrain. Int J Infect Dis
2020;101:14–6. https://doi.org/10.1016/j.ijid.2020.09.1433.
[10] Yassin MA, Soliman AT, de Sanctis V, Abdula MA, Riaz LM, Ghori
FF, Yousaf A, Nashwan AJ, Abusamaan S, Moustafa A, Kohla S. Statural
growth and prevalence of endocrinopathies in relation to liver iron
content (LIC) in adult patients with beta thalassemia major (BTM) and
sickle cell disease (SCD). Acta Bio Medica: Atenei Parmensis.
2018;89(Suppl 2):33.
[11] Sivalingam T, Inusa B, Doyle P, Oteng‐Ntim E. COVID‐19 and the
pulmonary complications of sickle cell disease. EJHaem 2020:545–7.
https://doi.org/10.1002/jha2.105.
[12] Sheha D, El-Shayeb M, Eid Y, Amin M, Saeed A, Abdou D, et al.
Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19)
infection. Br J Haematol 2020;191:e38–40.
https://doi.org/10.1111/bjh.17089.
[13] London S, London S. Ase eports 2020;105:2691–3.
[14] Torti L, Maffei L, Sorrentino F, De Fabritiis P, Miceli R,
Abruzzese E. Impact of SARS CoV-2 in hemoglobinopathies: a protective
mechanism being from Beta chain Hemoglobin defects? Mediterr J Hematol
Infect Dis 2020;12:e2020052. https://doi.org/10.4084/mjhid.2020.052.
[15] wenzhong liu, hualan L. COVID-19: Attacks the 1-Beta Chain of
Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism
2020. https://doi.org/10.26434/CHEMRXIV.11938173.V7.